SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012697
Filing Date
2020-11-05
Accepted
2020-11-05 07:10:34
Documents
94
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcyc-20200930x10q.htm 10-Q 2371588
2 EX-4.1 bcyc-20200930ex41acb0f9b.htm EX-4.1 57810
3 EX-31.1 bcyc-20200930ex311e5aee2.htm EX-31.1 13754
4 EX-31.2 bcyc-20200930ex312a44af4.htm EX-31.2 13734
5 EX-32.1 bcyc-20200930ex3213d3262.htm EX-32.1 10987
  Complete submission text file 0001558370-20-012697.txt   9528087

Data Files

Seq Description Document Type Size
6 EX-101.INS bcyc-20200930.xml EX-101.INS 1880535
7 EX-101.SCH bcyc-20200930.xsd EX-101.SCH 89027
8 EX-101.CAL bcyc-20200930_cal.xml EX-101.CAL 50789
9 EX-101.DEF bcyc-20200930_def.xml EX-101.DEF 355532
10 EX-101.LAB bcyc-20200930_lab.xml EX-101.LAB 641194
11 EX-101.PRE bcyc-20200930_pre.xml EX-101.PRE 543639
Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Filer) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38916 | Film No.: 201288641
SIC: 2834 Pharmaceutical Preparations